HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 02/05/2013 -- Opexa Therapeutics, Inc. (NASDAQ:OPXA) is rising nearly 300%; announced the execution of an agreement with Merck Serono, a division of Merck, Darmstadt, Germany, for the development and commercialization of Tcelna (imilecleucel-T), a potential first-in-class personalized T-cell therapy for patients suffering from multiple sclerosis. Tcelna is being developed by Opexa and currently is in a Phase IIb clinical trial in patients with Secondary Progressive MS. Potential payments to Opexa from the option and license agreement could total $225 million based upon the successful development and commercialization of Tcelna for MS.
How Should Investors React To OPXA Now? Find Out Here
Virgin Media Inc. (NASDAQ:VMED) is +6.32 at $45.01.VMED is scheduled to provide an earnings report on 2/6/2013, for the fiscal quarter ending Dec2012. The consensus earnings per share forecast is 0.41 per share, which represents a 26 percent increase over the EPS one Year Ago.
Will New Regulations Weigh over VMED Revenue Stream? Find Out Here
Protalix (NYSE:PLX) are soaring after Israeli website Calcalist reported that the company is in talks to be acquired for $1B. Pfizer has expressed interest in buying Protalix, but at a valuation below the amount that Protalix is seeking, the website added. Protalix's board has selected Citigroup to manage the selling process, according to Calcalist. In early trading, Protalix jumped 94c, or 18%, to $6.34.
What Are PLX’s Charts Signaling For Traders? Find Out Here
Zynga Inc. (NASDAQ:ZNGA) saw its shares jump nearly 6% to $2.70 on Tuesday morning after Bank of America/Merrill Lynch upgraded the stock to a buy rating. The move comes just ahead of the social game maker's fourth-quarter results, due after the closing bell. In his note to clients, analyst Justin Post cited "asset value and mobile stabilization" as the reason for his action, noting that the company has about $2.20 per share in cash and assets.
Is ZNGA a Solid Investment at These Levels? Find Out Here
Bank of America Corp (NYSE:BAC) began the trading session with a price of US$11.58 and throughout the session slide to a low of US$11.46. When day-trade ended, the stock finally dropped 1.96% to US$11.48. The company shareholders still have 46.43% gain in the past 52 weeks.
Can BAC Continue To Move Higher? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)